See also this year's filing and all EDGAR filings for this company.
PDF Report 0001722964_2020_Y_mAbs_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001722964, Y mAbs Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 211,955,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,052,000 |
| 3 | remainder_Assets | 2,359,000 |
| 4 | LiabilitiesCurrent | 13,586,000 |
| 5 | LiabilitiesNoncurrent | 1,956,000 |
| 6 | remainder_Liabilities | 1,921,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,512,000 |
| 9 | ResearchAndDevelopmentExpense | 63,492,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,976,000 |
| 13 | remainder_ComprehensiveNetIncome | 43,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 216,366,000 |
| 1 | Liabilities | 17,463,000 |
| 2 | Expenses | 83,004,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 198,903,000 |
| 5 | NetIncome | -81,028,000 |
| 6 | ComprehensiveNetIncome | -81,006,500 |
| 7 | BaseVar | 159,426,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.02 |
| 9 | EconomicCapitalRatio | 3.70 |